Arcturus Therapeutics Holdings Inc
ARCT
Market Cap$461.9M
Close$
$-26.42
248% downside
Current Fair Value
248% downsideOvervalued by 248% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $461.90 Million |
|---|---|
| Enterprise Value | $299.63 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-3 |
| Beta | 2.27 |
| Outstanding Shares | 27,129,000 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -7.67 |
|---|---|
| PEG | 16.43 |
| Price to Sales | 4.46 |
| Price to Book Ratio | 2.23 |
| Enterprise Value to Revenue | 2.49 |
| Enterprise Value to EBIT | -5.18 |
| Enterprise Value to Net Income | -7 |
| Total Debt to Enterprise | 0.11 |
| Debt to Equity | 0.15 |
Revenue Sources
No data
Insider Trades
ESG Score
No data